DR REDDYS LABORATORIES LTD
RDYDr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How RDY's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DFD05 Cream | Phase 2 | Common Warts | - | - |
Frequently asked questions
What is in DR REDDYS LABORATORIES LTD's drug pipeline?→
CatalystAlert tracks 1 drug candidate in DR REDDYS LABORATORIES LTD's (RDY) pipeline across Phase 2. Its lead program is DFD05 Cream (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is DR REDDYS LABORATORIES LTD's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for DR REDDYS LABORATORIES LTD (RDY) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track RDY biotech catalysts?→
Add RDY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow DR REDDYS LABORATORIES LTD's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.